Showing results (1-10 of 638) with videos related to
Sort By:
Pageof 64
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
Bisphosphonate treatment for multiple myelomaEvangelos Terpos, Amin RahemtullaBMJ Clinical Evidence|October 27, 2015
Hodgkin's lymphoma (relapsed or refractory): autologous stem cell therapyAmin Rahemtulla, Evangelos TerposBlood Reviews|March 8, 2005
The role of markers of bone remodeling in multiple myelomaEvangelos Terpos, Marianna Politou, Amin RahemtullaJournal of Cancer Research and Clinical Oncology|September 28, 2004
Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administrationEvangelos Terpos, Marianna Politou, Amin RahemtullaExpert Opinion on Pharmacotherapy|June 17, 2005
Current treatment options for myelomaEvangelos Terpos, Amin Rahemtulla, Meletios-Athanassios DimopoulosLeukemia & Lymphoma|November 3, 2005
Significance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myelomaEvangelos Terpos, Marianna Politou, Nora Viniou, et al.British Journal of Haematology|November 18, 2003
Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemiaErsi Voskaridou, Evangelos Terpos, Giovanna Spina, et al.British Journal of Haematology|September 27, 2003
Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myelomaEvangelos Terpos, Marianna Politou, Richard Szydlo, et al.Pageof 64